DaVita Inc. $DVA Shares Sold by Applied Finance Capital Management LLC

Applied Finance Capital Management LLC lowered its position in shares of DaVita Inc. (NYSE:DVA) by 25.5% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,953 shares of the company’s stock after selling 670 shares during the period. Applied Finance Capital Management LLC’s holdings in DaVita were worth $278,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also recently added to or reduced their stakes in DVA. Concurrent Investment Advisors LLC acquired a new stake in DaVita during the first quarter worth $223,000. Wealth Enhancement Advisory Services LLC increased its position in shares of DaVita by 22.5% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 4,351 shares of the company’s stock worth $666,000 after purchasing an additional 800 shares during the last quarter. Envestnet Asset Management Inc. increased its position in shares of DaVita by 7.9% during the 1st quarter. Envestnet Asset Management Inc. now owns 55,255 shares of the company’s stock worth $8,452,000 after purchasing an additional 4,048 shares during the last quarter. OneDigital Investment Advisors LLC acquired a new position in DaVita in the first quarter valued at about $200,000. Finally, Teacher Retirement System of Texas purchased a new position in DaVita during the first quarter worth about $1,010,000. 90.12% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

DVA has been the topic of several recent analyst reports. Barclays decreased their price objective on shares of DaVita from $160.00 to $149.00 and set an “equal weight” rating on the stock in a report on Thursday, October 9th. Bank of America decreased their price target on DaVita from $145.00 to $140.00 and set an “underperform” rating on the stock in a research note on Wednesday, September 10th. Truist Financial set a $140.00 price objective on DaVita in a research note on Tuesday. Weiss Ratings reissued a “hold (c+)” rating on shares of DaVita in a research note on Wednesday, October 8th. Finally, Wall Street Zen downgraded DaVita from a “buy” rating to a “hold” rating in a research report on Saturday, October 11th. Four research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Reduce” and a consensus price target of $153.25.

Insider Transactions at DaVita

In related news, insider James O. Hearty sold 2,351 shares of the business’s stock in a transaction dated Wednesday, July 23rd. The stock was sold at an average price of $150.00, for a total value of $352,650.00. Following the transaction, the insider owned 26,038 shares in the company, valued at $3,905,700. The trade was a 8.28% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. 1.50% of the stock is owned by company insiders.

DaVita Trading Up 0.4%

NYSE:DVA opened at $125.79 on Friday. DaVita Inc. has a 12-month low of $122.93 and a 12-month high of $179.60. The firm has a market cap of $8.99 billion, a PE ratio of 12.37, a price-to-earnings-growth ratio of 0.90 and a beta of 1.13. The stock has a fifty day moving average price of $132.49 and a 200 day moving average price of $138.31.

DaVita (NYSE:DVA) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $2.95 earnings per share for the quarter, topping the consensus estimate of $2.70 by $0.25. The company had revenue of $3.38 billion for the quarter, compared to the consensus estimate of $3.36 billion. DaVita had a return on equity of 369.39% and a net margin of 6.35%.DaVita’s revenue was up 6.1% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.00 EPS. DaVita has set its FY 2025 guidance at 10.200-11.300 EPS. Equities analysts forecast that DaVita Inc. will post 10.76 EPS for the current year.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.